<DOC>
	<DOC>NCT02948387</DOC>
	<brief_summary>Determine if antibiotic prophylaxis with intravenous cephalosporin and aminoglycoside in patients with Type II and II open fractures is safe and effective.</brief_summary>
	<brief_title>Preventing Infections in Orthopaedic Patients</brief_title>
	<detailed_description>1. Determine the safety and efficacy of antibiotic prophylaxis in type II and II open fractures when using IV Cephalosporin and aminoglycoside. 2. Identify the incidence of acute kidney injury. 3. Identify the type and number of associated infections 4. Identify the antibiotic resistance profile noted 5. Identify any secondary infections at sites other than the fracture site</detailed_description>
	<mesh_term>Fractures, Bone</mesh_term>
	<mesh_term>Fractures, Open</mesh_term>
	<criteria>Male or Female &gt;= 18 years old Patients are diagnosed with a Type II or III open fracture Prior to treatment, report of an allergy to betalactam or aminoglycoside antibiotics pregnancy did not receive 72 hours of IV antibiotic prophylaxis with 1st or 2nd generation cephalosporin and either gentamicin or tobramycin receiving ongoing inpatient care</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2016</verification_date>
</DOC>